HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic options in childhood nocturnal enuresis.

Abstract
Monosymptomatic nocturnal enuresis, a heterogeneous condition, is frequently treated in children aged >5 years. Of the various treatment options, enuresis alarm has been widely advocated as being effective for treating nocturnal enuresis, while extracorporeal pelvic floor magnetic stimulation for overactive bladder, urge incontinence and urgency-frequency syndrome has not yet been confirmed by controlled studies as primary treatment for monosymptomatic nocturnal enuresis. Desmopressin, an antidiuretic hormone (ADH) analog, or arginine vasopressin (AVP), can resolve primary nocturnal enuresis by decreasing night-time urine production. Enuretic children requiring either desmopressin or desmopressin plus oxybutynin to achieve dryness have polyuria. Tricyclic antidepressants (i.e. imipramine) are used successfully in enuretic children. Although tricyclics and desmopressin are effective in reducing the number of wet nights, most children relapse after discontinuation of active treatment. Combined therapy (enuresis alarm, bladder training, motivational therapy and pelvic floor muscle training) is more effective than each component alone or than pharmacotherapy. Furthermore, desmopressin combined with alarm therapy has a positive effect on enuresis. Pharmacotherapy can provide early relief of enuresis, while behavioral intervention may lead to greater long-term benefits. The positive effect of achieving dry nights with pharmacotherapy can encourage the child to sustain behavioral therapy.
AuthorsM Zaffanello, L Giacomello, M Brugnara, V Fanos
JournalMinerva urologica e nefrologica = The Italian journal of urology and nephrology (Minerva Urol Nefrol) Vol. 59 Issue 2 Pg. 199-205 (Jun 2007) ISSN: 0393-2249 [Print] Italy
PMID17571056 (Publication Type: Journal Article, Review)
Chemical References
  • Antidiuretic Agents
  • Mandelic Acids
  • Parasympatholytics
  • Arginine Vasopressin
  • Deamino Arginine Vasopressin
  • oxybutynin
Topics
  • Antidiuretic Agents (therapeutic use)
  • Arginine Vasopressin (therapeutic use)
  • Behavior Therapy
  • Child
  • Child, Preschool
  • Deamino Arginine Vasopressin (therapeutic use)
  • Drug Therapy, Combination
  • Exercise Therapy
  • Humans
  • Mandelic Acids (therapeutic use)
  • Motivation
  • Nocturnal Enuresis (therapy)
  • Parasympatholytics (therapeutic use)
  • Toilet Training
  • Treatment Outcome
  • Urodynamics (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: